3-Cyclopropyl-1-(2,5-dichlorobenzenesulfonyl)-1H-pyrazole

Catalog No. :
ACCVJW895
CAS No. :
956371-55-4
Molecular Formula :
C12H10Cl2N2O2S
Molecular Weight :
317.20

IUPAC Name:3-cyclopropyl-1-((2,5-dichlorophenyl)sulfonyl)-1H-pyrazole

3-Cyclopropyl-1-(2,5-dichlorobenzenesulfonyl)-1H-pyrazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$589.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Cyclopropyl-1-(2,5-dichlorobenzenesulfonyl)-1H-pyrazole
IUPAC Name3-cyclopropyl-1-((2,5-dichlorophenyl)sulfonyl)-1H-pyrazole
MDL No.MFCD03305844
Molecular FormulaC12H10Cl2N2O2S
Molecular Weight317.20
SMILESO=S(N1N=C(C2CC2)C=C1)(C3=CC(Cl)=CC=C3Cl)=O
InChI KeyIDISTYJHPGXFLR-UHFFFAOYSA-N
Synonym3-CYCLOPROPYL-1-[(2,5-DICHLOROPHENYL)SULFONYL]-1H-PYRAZOLE;3-cyclopropyl-1-(2,5-dichlorobenzenesulfonyl)-1H-pyrazole;1H-Pyrazole, 3-cyclopropyl-1-[(2,5-dichlorophenyl)sulfonyl]-
CAS No.956371-55-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACCVJW895 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHNGV027 route compound structure diagram
    ACHNGV027100114-57-6 In Stock
  4. Then
  5. ACCVJW895 route product structure diagram
    ACCVJW895956371-55-4
Inquiry

2. ACCVJW895 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAQNU854 route compound structure diagram
    ACAQNU854411235-57-9 In Stock
  4. Then
  5. ACCVJW895 route product structure diagram
    ACCVJW895956371-55-4
Inquiry

Comments (0)